BioSpace News Archive

TRANSGENE, a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, announces that Management will participate in several investor events, as set out below.

Ascendis Pharma A/S (Nasdaq: ASND) today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion and recommended the approval of TransCon PTH (palopegteriparatide) as a parathyroid hormone (PTH) replacement therapy indicated for the treatment of adults with chronic hypoparathyroidism.

Automated Control Concepts, a leading innovator in biotechnology solutions, announced the next release of its cutting-edge bioreactor control and data platform, Lab Owl, with new advancements that promise to redefine the landscape of bioprocessing.

Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a Canadian psychedelics drug research and formulation company, is pleased to see the positive and encouraging outcomes from the MAPS Phase 3 MDMA-Assisted Therapy (MDMA-AT) Clinical Trial published today on Nature Medicine.

Acticor Biotech, (ISIN: FR0014005OJ5 - ALACT) (Paris:ALACT), a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug for the treatment of cardiovascular emergencies, announced today its optimised development plan for Acute Ischemic Stroke (AIS) to register glenzocimab in Europe and the United States.

Attendees at this year’s American Orthopaedic Foot & Ankle Society annual meeting in Louisville, Kentucky will be the first to see Medline UNITE’s new REFLEX TETRA Nitinol Staples.